Significant reduction of body weight, hs-CRP, IL-6, IL-7, IL-18 and insulin resistance in intervention group. Endothelial function score improved in the intervention group. MD might be effective at reducing the prevalence of MS and its associated cardiovascular risk. Here, IL18 is linked to Insulin resistance.